Valsartan pharmacokinetics in patients with controlled and uncontrolled arterial hypertension
Open Access
- 23 May 2025
- journal article
- Published by Publishing House OKI in Pharmacokinetics and Pharmacodynamics
- No. 1,p. 69-75
Abstract
Relevance. Arterial hypertension (AH) is widespread throughout the world. Unfortunately, only a small proportion of patients achieve target blood pressure (BP). One of the possible reasons for the ineffectiveness of AH treatment is the pharmacokinetics of antihypertensive drugs.Objective. To test valsartan pharmacokinetics in patients with AH.Material and methods. An open cohort study was conducted. The analysis included 28 patients, including 15 (53.6 %) with uncontrolled AH. All patients regularly took valsartan, amlodipine, indapamide for a month. In the morning before and 2 hours after taking valsartan, venous blood samples were taken from all patients to assess its concentration using high-performance liquid chromatography with tandem mass spectrometry.Results. Patients of the two groups were comparable in terms of major comorbidities. C0h and C2h of valsartan did not statistically differ in patients with controlled and uncontrolled AH. In 39.3 % of patients, C0h and C2h of valsartan were within the therapeutic range (TD). In 50 % of patients, C0h did not reach the lower limit of TD, and in three patients, the concentration of valsartan exceeded the upper limit of TD, in one of them it exceeded the upper limit of TD almost three times. In 13 patients for whom valsartan was not recommended, it was found in trace amounts.Conclusion. Thus, to improve the efficacy and safety of valsartan therapy, it is advisable to monitor its concentration in the blood serum.Keywords
This publication has 19 references indexed in Scilit:
- Development and Validation of a Method for Quantification of Lisinopril, Indapamide, Metoprolol, Valsartan, and Amoldipine in Human Blood Serum by HPLC-MS/MSPharmaceutical Chemistry Journal, 2024
- Screening of cardiovascular agents in plasma with LC-MS/MS: A valuable tool for objective drug adherence assessmentJournal of Chromatography B, 2019
- Assessment of Patient Medication Adherence, Medical Record Accuracy, and Medication Blood Concentrations for Prescription and Over-the-Counter MedicationsJAMA Network Open, 2018
- Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysisThe Lancet, 2016
- 2013 ESH/ESC Guidelines for the management of arterial hypertensionEuropean Heart Journal, 2013
- The Impact of Intestinal Failure on Oral Drug Absorption: A ReviewJournal of Gastrointestinal Surgery, 2010
- Hypertension Control at Physicians' Offices in the United StatesAmerican Journal of Hypertension, 2008
- Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studiesThe Lancet, 2002
- Clinical pharmacokinetics of angiotensin II (AT1) receptor blockers in hypertensionJournal of Human Hypertension, 2000
- Pharmacokinetics, disposition and biotransformation of [14C]-radiolabelled valsartan in healthy male volunteers after a single oral doseXenobiotica, 1997